Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 91 (9), 4096-100

L-735,524: An Orally Bioavailable Human Immunodeficiency Virus Type 1 Protease Inhibitor

Affiliations

L-735,524: An Orally Bioavailable Human Immunodeficiency Virus Type 1 Protease Inhibitor

J P Vacca et al. Proc Natl Acad Sci U S A.

Abstract

To date, numerous inhibitors of the human immunodeficiency virus type 1 protease have been reported, but few have been studied extensively in humans, primarily as a consequence of poor oral bioavailability in animal models. L-735,524 represents a class of human immunodeficiency virus type 1 protease inhibitors, termed hydroxyaminopentane amides, that incorporate a basic amine into the hydroxyethylene inhibitor backbone. L-735,524 is a potent inhibitor of virus replication in cell culture and inhibits the protease-mediated cleavage of the viral precursor polyproteins that results in the production of noninfectious progeny viral particles. The compound is effective against viruses resistant to reverse transcriptase inhibitors and is synergistically active when used in combination with reverse transcriptase inhibitors. Most importantly, L-735,524 exhibits good oral bioavailability and plasma pharmacokinetic profiles in two species of laboratory animals by using clinically acceptable formulations. Accordingly, the compound was selected for evaluation of safety and pharmacokinetic studies in humans.

Similar articles

See all similar articles

Cited by 80 articles

See all "Cited by" articles

References

    1. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6612-6 - PubMed
    1. J Med Chem. 1992 May 15;35(10):1702-9 - PubMed
    1. Nature. 1985 Jan 24-30;313(6000):277-84 - PubMed
    1. Science. 1990 Apr 20;248(4953):358-61 - PubMed
    1. Science. 1985 Aug 9;229(4713):563-6 - PubMed

LinkOut - more resources

Feedback